CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology$1. .$1
Complex biologicals β’ vaccines β’ plasma and plasma derived therapeutics β’ biotechnology
10,000+
π° $111M Post-IPO Equity on 2004-02
October 4
10,000+
Director at CSL Behring shaping AI Platform for scalable solutions.
πΊπΈ United States β Remote
π΅ $190k - $260k / year
π° $111M Post-IPO Equity on 2004-02
β° Full Time
π΄ Lead
π¬ Director
September 16
10,000+
Lead CSL Vifor's policy and public affairs strategies in healthcare
π¨π Switzerland β Remote
π° $111M Post-IPO Equity on 2004-02
β° Full Time
π΄ Lead
π¬ Director
September 16
10,000+
Promote vaccine sales as a field-based specialist for CSL Seqirus.
πΊπΈ United States β Remote
π° $111M Post-IPO Equity on 2004-02
β° Full Time
π’ Junior
π€ Sales